Related Experiment Video
Updated: Mar 6, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
B Li1,2,3, W W Xu1,2, L Han1,2
1School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, China.
Abstract:
Esophageal cancer is one of the most lethal cancers worldwide with poor survival and limited therapeutic options. The discovery of microRNAs created a new milestone in cancer research. miR-377 is located in chromosome region 14q32, which is frequently deleted in esophageal squamous cell carcinoma (ESCC), but the biological functions, clinical significance and therapeutic implication of miR-377 in ESCC are largely unknown. In this study, we found that miR-377 expression was significantly downregulated in tumor tissue and serum of patients with ESCC. Both tumor tissue and serum miR-377 expression levels were positively correlated with patient survival. Higher serum miR-377 expression was inversely associated with pathologic tumor stage, distant metastasis, residual tumor status and chemoradiotherapy resistance. The roles of miR-377 in suppressing tumor initiation and progression, and the underlying molecular mechanisms were investigated. Results of in vitro and in vivo experiments showed that miR-377 overexpression inhibited the initiation, growth and angiogenesis of ESCC tumors as well as metastatic colonization of ESCC cells, whereas silencing of miR-377 had opposite effects. Mechanistically, miR-377 regulated CD133 and VEGF by directly binding to their 3' untranslated region. Moreover, systemic delivery of formulated miR-377 mimic not only suppressed tumor growth in nude mice but also blocked tumor angiogenesis and metastasis of ESCC cells to the lungs without overt toxicity to mice. Collectively, our study established that miR-377 plays a functional and significant role in suppressing tumor initiation and progression, and may represent a promising non-invasive diagnostic and prognostic biomarker and therapeutic strategy for patients with ESCC.
Insights
MicroRNA-377 (miR-377) is downregulated in esophageal squamous cell carcinoma (ESCC). Restoring miR-377 inhibits ESCC growth and metastasis, suggesting its potential as a diagnostic biomarker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Esophageal cancer, particularly ESCC, has poor survival rates and limited treatment options.
- MicroRNAs (miRNAs) are emerging as critical regulators in cancer development.
- The role of miR-377 in ESCC remains largely unexplored despite its location on a frequently deleted chromosome region.
Purpose of the Study:
- To investigate the biological functions, clinical significance, and therapeutic potential of miR-377 in esophageal squamous cell carcinoma (ESCC).
- To determine the correlation between miR-377 expression levels and patient survival, tumor stage, metastasis, and treatment response.
- To elucidate the molecular mechanisms by which miR-377 affects ESCC initiation and progression.
Main Methods:
- Quantitative analysis of miR-377 expression in ESCC tumor tissues and patient serum.
- Correlation analysis between miR-377 levels and clinical parameters (survival, tumor stage, metastasis, treatment resistance).
- In vitro and in vivo experiments to assess the effects of miR-377 overexpression and silencing on ESCC cell behavior and tumor growth.
- Mechanistic studies involving direct binding analysis of miR-377 to target genes (CD133, VEGF).
- Evaluation of systemic delivery of miR-377 mimics in a mouse model.
Main Results:
- miR-377 expression was significantly downregulated in ESCC tumor tissues and serum.
- Lower miR-377 levels correlated with poorer patient survival, advanced tumor stage, metastasis, and chemoradiotherapy resistance.
- Overexpression of miR-377 inhibited ESCC initiation, growth, angiogenesis, and metastasis in vitro and in vivo.
- miR-377 directly targets and regulates CD133 and VEGF.
- Systemic delivery of miR-377 mimic suppressed tumor growth, angiogenesis, and lung metastasis in mice without significant toxicity.
Conclusions:
- miR-377 functions as a tumor suppressor in ESCC by inhibiting initiation, progression, and metastasis.
- miR-377 holds promise as a non-invasive diagnostic and prognostic biomarker for ESCC.
- Restoring miR-377 levels represents a potential therapeutic strategy for ESCC patients.
Related Concept Videos
MicroRNAs
MicroRNAs
Mitogens and the Cell Cycle
Experimental RNAi
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation

